Bayer, Precision BioSciences in Crop Genome Modification Alliance | GenomeWeb

NEW YORK (GenomeWeb News) – Bayer CropScience, the agricultural subsidiary of Bayer, and Precision BioSciences announced today that they will collaborate on creating site-specific genome modifications in plants.

Under the deal, Bayer will have non-exclusive access to Precision Bio's Direct Nuclease Editor technology, which can be used to develop novel traits in plants, the firms said. Precision Bio also will supply Bayer with multiple DNE-engineered enzymes for use across the company's crop platforms.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.